Critical Patenting Issues on Pharma and Biosimilars

Critical Patenting Issues on Pharma and Biosimilars

 

  • Mumbai Workshop (19-Sept-15)

    Includes access to the workshop sessions, workshop documentation and lunch.

    Sale Date Ended

    INR 5000
    Sold Out
  • Hyderabad Workshop (26-Sept-15)

    Includes access to the workshop sessions, workshop documentation and lunch.

    Sale Date Ended

    INR 5000
    Sold Out

Invite friends

Contact Us

Page Views : 193

About The Event

ITAG Business Solutions Ltd. in association with Pharmexcil and Schwegman Lundberg & Woessner (USA), is organizing a one-day workshop on 'Critical Patenting Issues on Pharma and Biosimilars'. The workshop will be held in Mumbai on 19th September, 2015 at Taj Lands End, and in Hyderabad on 26th September, 2015 at Taj Krishna.

 

The workshop will address several opportunities available to today’s generic pharmaceutical companies, as well as the complexities, conundrums and challenges these opportunities bring. Some of the topics that would be covered during the workshop are:

 

  • Inter partes review (IPR)
  • Biosimilars
  • Risk evaluation and mitigation strategy (REMS)
  • Patent eligible subject matter

 

Speakers -

  • Gary Speier, Principal, Schwegman Lundberg & Woessner
  • Dr. Monique Perdok, Principal, Schwegman Lundberg & Woessner
  • Jeffer Ali, Partner, Carlson Caspers Vandenburgh Lindquist & Schuman, PA
  • Sarah M. Stensland, Partner, Carlson Caspers Vandenburgh Lindquist & Schuman, PA
  • Hari Subramanian, Managing Partner, Subramanian Nataraj & Associates
  • Dr. Dhanpat Ram Agarwal, Founder Director, ITAG Business Solutions Ltd.

 

Registration fee is Rs. 5,000 (Five Thousand Only).

 

Fore more information visit our website www.iprworkshop.com.